Doctor Giuseppe Banna Skip to main content

Doctor Giuseppe Banna

Consultant medical oncologist

About

I am a consultant medical oncologist specialising in the treatment of bladder cancer, genito (urinary cancer), kidney cancer, lung cancer and prostate cancer. My professional objective to offer the patient the best-individualised treatment and support.

In the last three years, I worked as the lead of clinical and translational research for thoracic tumours at Candiolo Cancer Institute, FPO-IRCCS, Turin, Italy, clinician scientist and consultant for lung and urology tumours at the Lincolnshire United Hospitals, the University of Lincoln and Nottingham, and Portsmouth University NHS Hospitals Trust in the UK

I am also a consultant medical oncologist for lung and urology tumours at the department of oncology of Portsmouth Hospitals University NHS Trust and Honorary Associate Professor at the Faculty of Science and Health, School of Pharmacy and Biomedical Sciences, University of Portsmouth, UK.

My expertise and current scientific focus is on: anticancer systemic treatments (chemotherapy, immunotherapy, targeted agents and hormonal therapy) for lung cancer, prostate, bladder/urothelial, renal cancers and mesothelioma; development of predictive models for immunotherapy, particularly those incorporating blood immune-inflammatory indexes; conduction of systematic review and meta-analysis; design of investigator initiated studies with novel anticancer therapy combinations; development of projects for the assessment and monitoring of adherence to anticancer oral treatments; development of tools to facilitate frailty assessment in oncology.

I have been leading more than 20 clinical and translational commercial and academic studies for lung and urology as Principal Investigator and joining European research networks. I published about 200 scientific papers in peer-reviewed and indexed journals.

In addition to my clinical work, I am also proud to be: an Honorary Associate Professore at the Faculty of Science and Health, School of Pharmacy and Biomedical Sciences, University of Portsmouth, UK; Educational and Clinical Supervisor, Portsmouth Hospitals University NHS Trust; Scientific Consultant - Clinical Pharmacology, Oncology, AIFA - Italian Medicines Agency; Referee for international research committees like the International Committee for Clinical Cancer Research of the Institut National du Cancer, the Dutch Cancer Society (KWF Kankerbestrijding) and Qatar National Research Fund (QNRF); Principal Investigator or Co-Investigator of clinical trials at Portsmouth Hospitals University NHS Trust.

Treatments

Registered with

General Medical Council
Number: 7540897


Professional memberships

American Society for Clinical Oncology (ASCO) (since 2021)
European Organization for the Research and Treatment of Cancer (EORTC) (since 2016)
European Society for Medical Oncology (ESMO) (since 2021)
International Society of Geriatric Oncology (SIOG) (since 2021)
Italian Germ Cell Cancer Group (IGG) (since 2006)
MeetURO-Italian Network for Research in Urologic Oncology (since 2019)


Professional qualifications

MD, Specialist in Oncology / University of Padua, Italy / 2022
MD



Academic letters

MD, Honorary Associate Professor

Current NHS posts

Consultant Medical Oncologist at Queen Alexandra Hospital, Portsmouth Honorary Consultant Medical Oncologist at St Mary's Hospital, Isle of Wight Honorary Associate Professor, University of Portsmouth



Location

Use the relevant number provided below to call the location you'd like to visit

Spire Portsmouth Hospital
Private secretaries
Irene Randazzo
07925 519506